Further, we found that TGFB1, overexpressed in a progenitor-cell infiltrated group, was an important component for alternative angiogenic signaling in ccRCC, indicating that TGFB1 inhibitors might increase the sunitinib response. The gene discussed is TGFB1; the disease is nonpapillary renal cell carcinoma.